Parallax Volatility Advisers’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,273
Closed -$53K 2181
2023
Q4
$53K Buy
+3,273
New +$53.6K ﹤0.01% 1922
2019
Q3
Sell
-11
Closed 3068
2019
Q2
$0 Sell
11
-7,889
-100% -$173K ﹤0.01% 3335
2019
Q1
$162K Buy
7,900
+5,318
+206% +$92.4K ﹤0.01% 1966
2018
Q4
$33K Buy
+2,582
New +$38.5K ﹤0.01% 2315
2018
Q2
Sell
-980
Closed -$8K 2888
2018
Q1
$8K Sell
980
-7,462
-88% -$60.5K ﹤0.01% 1883
2017
Q4
$75K Buy
+8,442
New +$77.9K ﹤0.01% 2969

Other funds holding NEO

Parallax Volatility Advisers's NEO Position: Q1 2024 in Review

Parallax Volatility Advisers sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 3,273 shares — an estimated $53K sold.

Parallax Volatility Advisers first reported a position in NEO in Q4 2017 and held it in 6 quarters. The position peaked at $162K in Q1 2019. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • Parallax Volatility Advisers reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3,273 NeoGenomics shares in Q1 2024, an estimated $53K.
  • Parallax Volatility Advisers first reported a position in NeoGenomics in Q4 2017 and held it in 6 quarters.
  • Parallax Volatility Advisers's NeoGenomics position peaked at $162K in Q1 2019.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Parallax Volatility Advisers's 13F filing for Q1 2024, filed 15 May 2024.